Article: The Myc and Ras Partnership in Cancer: Indistinguishable Alliance or Contextual Relationship?

Myc and Ras are two of the most commonly activated oncogenes in tumorigenesis. Together and independently they regulate many cancer hallmarks including proliferation, apoptosis, and self-renewal. Recently, they were shown to cooperate to regulate host tumor microenvironment programs including host immune responses. But, is their partnership always cooperative or do they have distinguishable functions? Here, we provide one perspective that Myc and Ras cooperation depends on the genetic evolution of a particular cancer. This in turn, dictates when they cooperate via overlapping and identifiably distinct cellular- and host immune-dependent mechanisms that are cancer type specific.

Citing Articles

A stromal inflammasome Ras safeguard against Myc-driven lymphomagenesis.

Kent A, Yee Mon K, Hutchins Z, Putzel G, Zhigarev D, Grier A Nat Immunol. 2025; 26(1):53-67.

PMID: 39747433 DOI: 10.1038/s41590-024-02028-z.

Zuojin Pill Alleviates Precancerous Lesions of Gastric Cancer by Modulating the MEK/ERK/c-Myc Pathway: An Integrated Approach of Network Pharmacology, Molecular Dynamics Simulation, and Experimental Validation.

Liang L, He C, Han X, Liu J, Yang L, Chang F Drug Des Devel Ther. 2024; 18:5905-5929.

PMID: 39679136 PMC: 11646374. DOI: 10.2147/DDDT.S487371.

Unveiling the therapeutic promise: exploring Lysophosphatidic Acid (LPA) signaling in malignant bone tumors for novel cancer treatments.

Qi Y, Wang Y, Yuan J, Xu Y, Pan H Lipids Health Dis. 2024; 23(1):204.

PMID: 38943207 PMC: 11212261. DOI: 10.1186/s12944-024-02196-9.

Impact of Oncogenic Changes in p53 and KRAS on Macropinocytosis and Ferroptosis in Colon Cancer Cells and Anticancer Efficacy of Niclosamide with Differential Effects on These Two Processes.

Nguyen N, Sennoune S, Dharmalingam-Nandagopal G, Sivaprakasam S, Bhutia Y, Ganapathy V Cells. 2024; 13(11.

PMID: 38891084 PMC: 11171492. DOI: 10.3390/cells13110951.

Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer.

Hamilton G, Stickler S, Rath B Explor Target Antitumor Ther. 2023; 4(5):1027-1038.

PMID: 38023987 PMC: 10651355. DOI: 10.37349/etat.2023.00178.

References

1.

Kalluri R, LeBleu V . The biology function and biomedical applications of exosomes. Science. 2020; 367(6478). PMC: 7717626. DOI: 10.1126/science.aau6977. View

2.

Gouw A, Margulis K, Liu N, Raman S, Mancuso A, Toal G . The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth. Cell Metab. 2019; 30(3):556-572.e5. PMC: 6911354. DOI: 10.1016/j.cmet.2019.07.012. View

3.

Simanshu D, Nissley D, McCormick F . RAS Proteins and Their Regulators in Human Disease. Cell. 2017; 170(1):17-33. PMC: 5555610. DOI: 10.1016/j.cell.2017.06.009. View

4.

Boxer R, Jang J, Sintasath L, Chodosh L . Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. Cancer Cell. 2004; 6(6):577-86. DOI: 10.1016/j.ccr.2004.10.013. View

5.

Tran P, Bendapudi P, Lin H, Choi P, Koh S, Chen J . Survival and death signals can predict tumor response to therapy after oncogene inactivation. Sci Transl Med. 2011; 3(103):103ra99. PMC: 3966995. DOI: 10.1126/scitranslmed.3002018. View